Material Detail

"Clinical Care Options: Adjuvant HER2-Positive Cancer: Integrating Prognostic Tools and Clinical Advances to Optimize Treatment" icon

Clinical Care Options: Adjuvant HER2-Positive Cancer: Integrating Prognostic Tools and Clinical Advances to Optimize Treatment

This management series contains modules, interactive case challenges, and slidesets by experts concerning HER2-positive breast cancer. Topics include Current Clinical Data on Adjuvant Therapy for HER2-Positive Breast Cancer, Estimating Benefit and Prognosis With Adjuvant Therapy for HER2-Positive Breast Cancer, Treatment of a 32-Year-Old Patient With HER2-Positive Breast Cancer, Treatment of Breast Cancer in a 64-Year-Old Black Female With Multiple Positive Lymph Nodes, and Assessing Breast Cancer Prognosis and Applications for Clinical Practice. Membership is required to access material; membership is free.
Rate

Quality

  • Editor Reviews
  • User Rating
  • Comments
  • Learning Exercises
  • Bookmark Collections
  • Course ePortfolios
  • Accessibility Info

More about this material

Browse...

Disciplines with similar materials as Clinical Care Options: Adjuvant HER2-Positive Cancer: Integrating Prognostic Tools and Clinical Advances to Optimize Treatment

Comments

Log in to participate in the discussions or sign up if you are not already a MERLOT member.